Literature DB >> 16334138

Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features.

Yan Ansquer1, Laurent Mandelbrot, Thérèse Lehy, Laurence Salomon, Caroline Dhainaut, Patrick Madelenat, Gérard Feldmann, Francine Walker.   

Abstract

BACKGROUND: The BRCA1 caretaker gene is associated with poor prognostic features in hereditary breast cancer and may also play a role in sporadic breast cancer (SBC). HER-1 and HER-2 overexpression is associated with adverse prognosis in SBC. We studied whether BRCA1 expression was associated with HER1, HER2 and other prognostic features in SBC. PATIENTS AND METHODS: Fifty newly-diagnosed SBC patients were studied for prognostic features and immunohistochemical expressions of BRCA1, HER-1 and HER-2.
RESULTS: Tumors were positive for BRCA1 in 26%, HER-1 in 32% and HER-2 in 20% of cases. Lack of BRCA1 expression was associated with node metastases and decreased estrogen receptor. HER-2 expression was associated with young age, HER-1, Ki67 and decreased hormone receptors. No correlation was observed between BRCA1 and HER-1 or HER-2.
CONCLUSION: In SBC, the lack of BRCA1 expression was associated with poor prognostic features, but unrelated to HER-1 and HER-2. HER2 and HER-1 were, however, highly correlated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16334138

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture.

Authors:  Lei Duan; Gengsheng Chen; Sumeet Virmani; GuoGuang Ying; Srikumar M Raja; Byung Min Chung; Mark A Rainey; Manjari Dimri; Cesar F Ortega-Cava; Xiangshan Zhao; Robert J Clubb; Chun Tu; Alagarsamy L Reddi; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

2.  HER2 testing in the UK: consensus from a national consultation.

Authors:  Mitch Dowsett; A M Hanby; R Laing; R Walker
Journal:  J Clin Pathol       Date:  2007-02-23       Impact factor: 3.411

3.  Expression of ERBB gene family in females with breast cancer and its correlation with clinicopathological characteristics of the disease.

Authors:  Mohsen Soosanabadi; Arezoo Mosharraf Ghahfarokhi; Farzad Pourghazi; Naeim Ehtesham; Reza Mirfakhraie; Lilit Atanesyan; Elahe Keyhani; Farkhondeh Behjati
Journal:  Mol Biol Rep       Date:  2022-06-28       Impact factor: 2.742

4.  Elevated expression of E-cadherin in primary breast cancer and its corresponding metastatic lymph node.

Authors:  Lin Chen; Wei Jian; Leisheng Lu; Lijun Zheng; Zhen Yu; Donglei Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines.

Authors:  Darren Chyi-Hsiang Kong; Kenneth Yee Choy Chew; Eng Lai Tan; Suan Phaik Khoo
Journal:  Cancer Cell Int       Date:  2014-11-18       Impact factor: 5.722

6.  Comparison of BRCA1 Expression between Triple-Negative and Luminal Breast Tumors

Authors:  Farzaneh Darbeheshti; Pantea Izadi; Amir Nader Emami Razavi; Mir Saeed Yekaninejad; Javad Tavakkoly Bazzaz
Journal:  Iran Biomed J       Date:  2017-06-25

7.  Evaluation of Immunohistochemistry-Equivocal (2+) HER2 Gene Status in Invasive Breast Cancer by Silver DNA in Situ Hybridization (SISH) and its Association with Clinicopathological Variables.

Authors:  Zaidoon A Musa; Ban J Qasim; A Wahab A K Al Shaikhly
Journal:  Iran J Pathol       Date:  2016-08-30

8.  Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.

Authors:  Israa A Hussein; Shatha Th Ahmed; Ameer D Hameedi; Rana Z Naji; Layth Alharbawi; Muzahm Alkhaytt; Intisar S Pity
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.